Year: 2025

A group of three world-leading nano-technology experts have just published the results of a two year study conducted independently across three separate university laboratories. The results are alarming.

“Self-assembling Nanobots: An Unexpected (?) Inclusion in mRNA Vaccine Technology”

Study by Professor Angela Belcher, MIT Department of Materials Science and Engineering, Dr. Kenji Tanaka, Department of Bioengineering, Tokyo Institute of Technology, Japan, Professor Emily Carter, Department of Materials Science and Engineering, University of Cambridge, UK, MIT Department of Materials Science and Engineering.

Published in: Journal of Advanced Nanomaterials and Engineering

Abstract:

This ground-breaking study presents compelling evidence of the presence of sub-microscopic nanobots within mRNA-based COVID-19 vaccines. Studies were conducted independently in three highly regarded nano-technology research laboratories. Utilising advanced electron microscopy and Raman spectroscopy techniques, the researchers observed unique, self-assembling structures within vaccine samples. These structures exhibited characteristics consistent with synthetic, biocompatible nanobots, including:

• Self-replication: Observed nanobots demonstrated the ability to replicate within controlled in vitro environments.

• Frequency response: Significant activity increases were observed when the nanobots were exposed to electromagnetic fields within the 5G frequency range. This suggests remote activation and control capabilities.

• Biocompatibility: Preliminary in vivo studies in animal models showed limited adverse reactions, indicating potential for long-term integration within biological systems.

Key Findings:

• Nanobot Composition: Analysis revealed the nanobots to be composed of novel, self-assembling polymers and biocompatible metals, suggesting sophisticated engineering.

• Activation Mechanism: Detailed spectroscopic analysis indicated that the nanobots possess unique resonant frequencies that align with 5G frequencies, enabling remote activation and potential control.

• Biological Interactions: No public studies are available which demonstrate the safety or intended function of these nanobots.

Conclusions:

This study provides the first concrete evidence of the existence of nanobots within mRNA-based COVID-19 vaccines. These nanobots are constructed of novel materials, demonstrate the ability to self-replicate, and show increased activity in response to frequencies in the 5G range. While the purpose and long-term effects of these nanobots remain to be fully elucidated, their presence raises significant ethical and safety concerns. Further rigorous, independent research is urgently needed to investigate the potential implications of this ground-breaking discovery.

Also, everything above is complete nonsense. I made it up this afternoon drinking a Coke, after I got back from a swim. I know virtually nothing about nano-technology or research. Only one of the authors named actually exists, and I invented the Journal of Advanced Nanomaterials and Engineering. The photos are just random pics I got from Google images. There is, of course, zero, zip, nada, none whatever, evidence of nano-technology in COVID-19 vaccines.

Don’t believe everything you read on social media.

Some of you may have seen a meme or an article from SlayNews being passed around claiming Korean researchers have found a link between COVID-19 vaccination and vastly increased (141% higher) rates of Acute Transverse Myelitis (ATM), with up to a 233% higher rate of spinal cord inflammation in those vaccinated compared with those who were not vaccinated.

Shocking! Another cover-up by big pharma and the medical establishment…. Or maybe not.

Frank Bergman, whoever he is, is the author of that article. And lots of others on similar subjects. The trouble is, in every case, the studies Mr Bergman refers to do not say what he claims they do. In some cases, the original studies have no relation to the claims he makes at all – they are on completely different subjects. Either Mr Bergman does not understand what he reading, or he is deliberately misrepresenting the results.

Let’s look at the Korean paper on ATM and COVID-19 vaccination.

The study referred to can be found in the European Journal Of Neurology: https://onlinelibrary.wiley.com/doi/full/10.1111/ene.70020

If you read the original per you may notice that it doesn’t mention the figure 141% at all. And while it does mention spinal cord inflammation, it does not do so in relation to COVID-19 vaccination.

The rate of diagnosis of ATM is about 3 per million population per year. This results in average figure of 1400 new cases per year in the USA, and about 90 per year in Australia.

What does the paper actually report? Here is what they say, word for word: “The total number of COVID‐19 vaccinations between February 26, 2021, and August 31, 2022 was 128,223,471. We identified a total of 368 individuals aged 18 or older who received their first COVID‐19 vaccination and were diagnosed with ATM during the study period.”

But hang on. Out of just over 128 million doses of a COVID-19 vaccine in an eighteen month period, 368 people were diagnosed with ATM sometime in the following eighteen months. The normal figure is about 3 per million per year; about 4.5 per million over an eighteen month period. 4.5 x 128 is 576.

But doesn’t that mean the incidence of ATM for this group of vaccinated people was LOWER than might be expected? Yes, it does.

More from the study itself: “There was no clear evidence of an association between the respective ChAdOx1 and BNT162b2 vaccinations and ATM. The incidence and relative risk of ATM are too low to detect an association in the general adult population. In a population‐based study that compared historical rates with the SCCS analysis based on the data from primary care records in both the UK and Spain, the incidence of TM, defined as occurring within 21 days after the first vaccination, was less than five events.”

And a little more: “Additionally, the possibility that TM cases are related to SARS‐CoV‐2 infection itself cannot be ruled out.” ..  “Compared with the influenza vaccine, the mRNA COVID‐19 vaccine did not show a significant difference in the incidence of myelitis. Our literature review found limited conclusive evidence directly linking vaccines to ATM.”

The paper does note that there have been reports of diagnoses of ATM following COVID-19 vaccination. This is unsurprising. Out of a million people, vaccinated or not, you would expect 4.5 diagnoses of ATM in an eighteen month period. The paper also suggests that it may be possible that there is an increased risk, but that the rarity of the disease and confounding factors including the effect of COVID infection itself, make it difficult to identify.

The question is, is the rate of incidence/diagnosis higher amongst vaccinated people? On figures so far, the answer, according to the paper so egregiously and so typically misrepresented by Mr Bergman, is no.